Introduction {#sec1-1}
============

Septal deviations are the most common cause of nasal obstruction, representing a common compliant in rhinologic practice. Since its introduction, procedures for correction of nasal septal deformities have undergone several modifications, from radical septal resection, to possible preservation of septal framework and nasal mucosa. Frequently, septal deformities can be associated with lateral wall diseases or may be the cause of them. A significantly deviated nasal septum has been implicated in epistaxis, sinusitis, obstructive sleep apnoea and headaches attributable to contact point with structures of lateral nasal wall ^[@ref1]^.

For this reason, correction of septal deformities cannot be separated from treatment of disorders of the lateral wall when present. Thus, endoscopic septoplasty is a useful technique for treating symptomatic deformities, but also for improving intraoperative surgical access to lateral nasal wall surgeries (e.g. dacryocystorhinostomy, functional endoscopic sinus surgery) ^[@ref2]^ ^[@ref3]^.

Since the first description by Lanza et al. in 1991, the use of the endoscope for the correction of septal deformities is increasingly more frequent ^[@ref4]^.

In the literature there is an increase of the consensus in favour of endoscopic septoplasty compared to a conventional approach. However, to date, no author has focused attention on the effectivenes of endoscopic correction, considering all types of septal deformities. More than 20 years ago, Mladina published a systematic classification of septal deformities, precisely defining clinical findings at the nasal septum, and proposing seven different types of deformity ^[@ref5][@ref6]^.

The purpose of this study is to evaluate the effectivenes of the endoscopic septoplasty for the correction of each of the 7 types of septal deformities according to Mladina's classification.

Materials and methods {#sec1-2}
=====================

A retrospective chart review was performed in 184 consecutive patients presenting to our Department for endoscopic septoplasty during a 30-month period (February 2012 to August 2014). The patients were 22 females and 37 males with a mean age of 34.9 years, ranging from 18 to 69. Inclusion criteria were as follows: at least 17 years old, septal deformity with nasal obstruction, persistent symptoms after at least a 4-weeks of therapy including topical nasal steroids in combination or not with antihistamines. Patients with sinonasal malignancy, being in need of nasal surgery other than septoplasty (such as functional endoscopic sinus surgery -- FESS --, nasal valve surgery, turbinate surgery etc.), sinonasal infections, sinonasal inflammatory disease, were excluded from the study.

Given the presenting symptoms of patients that may suggest some forms of rhinosinusitis (chronic or acute recurrent forms), all patients were preoperatively evaluated by paranasal sinus computed tomography (CT) (120 kV, 215 mA s, 1 mm slice thickness).

Among the 184 patients studied, 125 were excluded for the presence of radiological signs of chronic rhinosinusitis with some anatomical variants as follows: inferior turbinate hypertrophy in 93% of cases, middle turbinate pneumatisation in 37% of cases, uncinate process pneumatisation in 8% and dysventilated sinuses in 60% of cases.

Therefore, 59 patients (32%) fulfilled the inclusion criteria for the present study. The most frequent symptoms encountered were nasal obstruction in all cases; facial pain in 27 cases and postnasal drip and headache in 7 cases each. All patients were submitted to allergic evaluations with skin prick tests for inhalants. The degree of septal deviation was calculated using OSIRIX^®^ Software (Pixameo SARL, Bernex, Switzerland, 2003-2014). The angle defined by a line passing through the most deviated point and a line perpendicular to the floor of the nose was calculated to determine the degree of the septal deviation ([Fig. 1](#fig001){ref-type="fig"}). Moreover, nasal spaces were directly assessed by nasal endoscopy in all cases.

Using these examinations, we were able to stratify the patient cohort into seven groups based on Mladina's classification of nasal septum deviation ([Table I](#table001){ref-type="table"}).

All patients included in our study underwent endoscopic septoplasty according to the technique described herein.

The procedure was performed under general anaesthesia. The septum was injected with 1% xylocaine in 1:20,000 epinephrine on the convex side of the septum using a 0° rigid 4 mm Hopkins Rod Lens endoscope.

In Mladina's type 5 and 6 (Cottle's area IV and V) deformity, a horizontal hemitransfixation incision was made, parallel to the nasal floor on the apex of the spur to expose the most deviated part ([Fig. 2a](#fig002){ref-type="fig"}). A submucoperichondral flap was raised using a Cottle elevator under endoscopic visualisation to expose the underlying bone at the most deviated part. To avoid contralateral mucosal damage, careful submucoperichondral dissection on the opposite side was performed using a Cottle elevator. Flaps were elevated superiorly and inferiorly to expose the underlying bony or cartilaginous spur ([Fig. 2b](#fig002){ref-type="fig"}). The bony protrusion was removed using a chisel placed on the base of the spur.

In Mladina types 2, 3 and 4 deformities (Cottle's area I, II, III), we performed an "endoscopic assisted septoplasty". A vertical incision was made on the concave side of the septum to expose the abnormality at the bony cartilaginous junction. The initial mucoperichondrial flap was elevated using Freer's elevator and nasal speculum. Further elevation was done using 0° rigid nasal endoscope (4 mm), held in the left hand, keeping the tip of the endoscope between the mucoperichondrial flap and the septal cartilage ([Fig. 2c](#fig002){ref-type="fig"}). The right hand was used for instrumentation. Flap elevation in the correct cleavage plane to minimise bleeding. Exposure was limited to the target area. A subluxated cartilage from the crest was shaved using a No. 15 blade Bard parker knife to resect the excess cartilage inferiorly, without dislocating the vomero-chondral junction ([Fig. 2d](#fig002){ref-type="fig"}).

In all cases mucosal flaps were repositioned back in place and is fixed using a silastic stent in order to avoid the mucosal damage during packing removal. Nasal packing was placed in both nasal fossae (Merocel, Medtronic, Mystic, CT, USA) and were removed after 48 hours.

Patients were usually discharged after 48 hours. All patients received post-operative antibiotic therapy with oral cephalosporin for one week, saline nasal douching and oral steroids with decreasing dosage.

The main outcome measure used in the study was the NOSE scale (Nasal Obstruction Symptom Evaluation) including a grading score from 0 to 5 ([Fig. 3](#fig003){ref-type="fig"}). All patients were asked to complete the NOSE scale one week before surgery and then at 3 and 6 months post-operatively. Nonparametric analysis (Wilcoxon signed rank test) was used to compare baseline and follow-up NOSE scores. P values \< 0.05 were considered statistically significant. For each deviation, descriptive statistics (mean and standard deviation, significant increase/decrease) were used to assess the possibility to correct each type of deviation.

Nasal endoscopy was performed in all patients at given intervals (15 days, 1 month, 3 months, and 6 months after surgery) to assess possible complications.

Results {#sec1-3}
=======

Mean follow-up time was 6.3 months (range 3-14 months).

The patient cohort was divided according to the Mladina classification as follows: type 5 was the most frequent deviation observed (23.7%, 14 cases); type 3 and 6 were also relatively frequent (20.3%, 12 cases and 18.6%, 11 cases, respectively); types 2 and 1 were observed in equal frequency (13.5%, 8 cases and 11.8%, 7 cases, respectively); types 4 and 7 were rare (6.7%, 4 cases and 5%, 3 cases, respectively).

The disease-specific QOL scores assessed with the NOSE scale at different intervals of time are detailed in [Table II](#table002){ref-type="table"}.

Compared to baseline, the scores registered at 3 and 6 months after surgery showed significant improvement in nasal symptoms (p \< 0.05). The results are shown in [Table III](#table003){ref-type="table"}.

Significant decreases in nasal obstruction, trouble sleeping, snoring and mouth dryness in the morning were observed between the preoperative period and 3 months after septoplasty. On the other hand, no statistically significant differences between the 3 and 6 month scores were observed.

The analysis of the NOSE scores for each deformity showed a different corrective power depending on the type of deviation treated. More in detail, the greater corrective capacity was found for the deviation types 5 and 6, and then gradually decreased for the septal deviation types 4, 1 and 7, becoming very limited for types 3 and 2. This trend remained unchanged over time (3 month - 6 month follow-up) ([Fig. 4](#fig004){ref-type="fig"}).

In our series, 1 septal abscess (Mladina type 4) and 1 saddle nose deformity (Mladina type 2) were reported after endoscopic septoplasty. No haematoma, no synechiae, or perforations were observed.

Discussion {#sec1-4}
==========

Over the years, many surgical techniques for the correction of septal deformity have become diffuse. The concept of septoplasty was firstly popularised by Killian (1904) ^[@ref7]^ and Freer (1902) ^[@ref8]^ separately more than 100 years ago. In 1947, Cottle defined surgical septoplasty as a treatment to correct nasal airway obstruction, and standardised the technique ^[@ref9]^. This technique has remained largely unchanged up to now. Recently introduced endoscopic endonasal techniques provide better magnification and illumination of the surgical field and can also be used to assist septal surgery ^[@ref11]^.

The application of endoscopic techniques for correction of septal deformities was initially described in 1991 by Stammberger. Since that time, surgeons have performed endoscopic septoplasties not only to treat symptomatic nasal obstruction, but also to improve surgical access to the middle meatus as an adjunct to endoscopic sinus surgery (ESS) ^[@ref10]^.

Endoscopic septoplasty is now an attractive alternative to traditional headlight approach for septoplasty.

Bothra et al. showed better results and fewer complications with endoscopic septoplasty compared to conventional approaches, as endoscopy gave better illumination and improved access to high deviations and spurs ^[@ref17]^.

The same opinion in favour of endoscopic septoplasty was expressed later by several authors who compared the two techniques ^[@ref18]^. Gulati et al ^[@ref19]^ found that an endoscopic approach to septoplasty simplifies identification of the pathology due to better illumination, improved accessibility to remote areas and magnification, while allowing for limited incision and elevation of flaps without compromising adequate exposure of the pathological site. Paradis et al. ^[@ref20]^ compared endoscopic vs classic septoplasty. The authors recruited 63 patients with a septal deviation meeting strict inclusion/exclusion criteria and measures outcomes including surgical time, intraoperative complications and pre- and post-operative data from the Nasal Obstruction Symptom Evaluation (NOSE) questionnaire. There were subjective improvements in nasal obstructive symptoms in both groups, but without significant differences between endoscopic and classic septoplasty. However, objective outcome measures, including operative time and intraoperative complications, were favoured by the endoscopic technique. Therefore, considering these findings and the advantages of endoscopy (e.g., improved visualisation of the surgical field, increased precision and enhanced teaching opportunity), the use of an endoscopic approach for septoplasty is suggested over a traditional technique for correction of septal deviation.

While the majority of authors seem to prefer the endoscopic technique, no one has analysed the effectiveness of this procedure in resolving different septal deformity.

To our knowledge, this is the first study that evaluates the corrective capacity of this technique for each type of deviation by analysing pre- and post-operative objective outcomes, as well as subjective outcomes gathered from the validated NOSE questionnaire ^[@ref21]^.

Mladina et al. codified a classification for septal deformity based on direct observations of 2589 patients. The authors concluded that almost 90% of subjects showed 1 of the 7 types of septal deformity described ^[@ref6][@ref24]^. We divided our cohort based on this simple and effective classification. By direct endoscopic visualisation and data processing of coronal CT scans, it was easily possible to stratify our sample into each of the seven types described by Mladina et al. ^[@ref6]^.

For those who deal with functional nasal surgery, evaluation of the nasal airflow perception is the most difficult parameter to study. Nasal breathing is a complex function of the nose that may be influenced by various conditions such as humidity, nasal resistance and contact of inspiration air with nasal surfaces. Stewart et al. in 2004 completed the validation of a disease-specific instrument to assess nasal obstruction: the NOSE scale ^[@ref25]^. According to Kahveci et al., who found the NOSE scale a very efficient tool to evaluate outcomes of septoplasty, we adopted this tool to assess the effectiveness of endoscopic septoplasty in different types deviations, comparing outcomes observed preoperatively and at 3 and 6 months post-operatively ^[@ref21]^.

Generally, turbinate surgery was not accepted as an exclusion criterion when functional outcomes of septoplasty were evaluated ^[@ref22]^ ^[@ref25][@ref26]^. However, we preferred to include only patients with septal deviation without any other confounding factors (e.g. inferior turbinate hypertrophy) to evaluate the efficiency of septoplasty.

Data analysis from the NOSE score showed a marked improvement in airflow perception in all patients treated. No significant differences were appreciated by comparing the NOSE score at 3 months and 6 months after surgery. According to Skitarelic et al., these findings showed that endoscopic septoplasty is an effective procedure with stable results over time ^[@ref19]^.

What we consider very interesting is that the analysis of the NOSE score for individual septal deformity highlighted a different efficacy of the surgical procedure. In particular, the corrective power seems to be greater for deviation types 5 and 6, gradually decreasing in types 4, 1 and 7 and becoming minimal for types 3 and 2. As already shown by Gupta et al., endoscopic vision allows excellent lighting of the septum in the rear portion (Cottle's area IV, V) and faciltates correction of all deviations in this area. Because deviations type 5 and 6 are located mainly in the posterior areas, this could explain the increased corrective power obtained for these deviations in our sample ^[@ref27][@ref28]^.

Nayak et al. reported that about 10% of cases with anterior septal deformity had persistent septal deviation after endoscopic septoplasty. In the same way, we have found greater difficulty in performing endoscopic procedure for deviations in this area (Cottle 's area I, II, III) ^[@ref11][@ref27]^.

In these areas, it is difficult to obtain a good endoscopic vision for the lack of support for the endoscope. Moreover, the elastic recoil of the cartilage requires detaching a large portion of the septum and to release it in the caudal portion. Therefore, significant bleeding requiring too frequent cleaning of the endoscope's tip render the procedure difficult in this area. We believe that this may explain the reduced corrective capacity of the endoscopic septoplasty for type 2, 3 and 7 deformities.

Conclusions {#sec1-5}
===========

This study has shown that the corrective power of endoscopic septoplasty is different according to the type of deviation. Even if endoscopic septoplasty may be considered as a reliable alternative to traditional techniques, it is essential to properly identify the type of deformity preoperatively in order to select the adequate surgical strategy. Long term follow-up and larger series are necessary to more accurately assess the indications and limitations of endoscopic-assisted septoplasty in all types of deviation.

![The seven types of septal deviations proposed by Mladina. In the first column, CT scans processed with OsiriX program are shown; the second column shows schematic illustrations for each deviation.](aoi-2018-04-323-g001){#fig001}

![Intraoperative picture showing: **a)** horizontal hemitransfixation incision parallel to the nasal floor on the apex of the septal spur; **b)** flaps elevation to expose the underlying bony or cartilaginous spur; **c)** 0° rigid nasal endoscope (4 mm), inserted between the mucoperichondrial flap and the septal cartilage; **d)** Cartilage excess resection without dislocating the vomero-chondral junction.](aoi-2018-04-323-g002){#fig002}

![The NOSE questionnaire.](aoi-2018-04-323-g003){#fig003}

![Percentages decreased for each deviation type at 3 months, 6 months and overall.](aoi-2018-04-323-g004){#fig004}

###### 

Classification proposed by Mladina.

  ------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Type 1**   Unilateral vertical septal ridge in the valve region that does not reach the valve itself; it does not change the physiologic valve angle (15%) and therefore usually plays just a mild role in the nasal pathophysiology
  **Type 2**   Unilateral vertical septal ridge in the valve region that touches the nasal valve, thus reducing the physiologic valve angle (15%)
  **Type 3**   Unilateral vertical ridge that is located more deeply in the nasal cavity, opposite the head of the middle turbinate
  **Type 4**   Bilateral deformity consisting of type 2 on one side and type 3 on the other
  **Type 5**   Almost horizontal septal spur that sticks laterally and deeply into the nasal cavity. The opposite side of the nasal septum is always flat
  **Type 6**   Massive unilateral intermaxillary bone wing with a "gutter" between it and the rest of the septum on this septal side. On the other septal side, there is an anteriorly positioned basal septal crest.
  **Type 7**   Very variable combination of the previous types
  ------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Our cohort divided according to the Mladina classification. Disease-specific QOL scores (mean and standard deviation) assessed with the NOSE scale at baseline; 3 and 6 months after surgery.

  Deviation   Sample rate (%)   Baseline     3 months     6 months
  ----------- ----------------- ------------ ------------ ------------
  I           11.8%             14.1 ± 1.2   12.3 ± 1.7   12.0 ± 1.9
  II          13.5%             16.0 ± 1.0   15.6 ± 1.0   15.5 ± 1.0
  III         20.3%             15.0 ± 0.8   14.5 ± 0.9   14.1 ± 0.6
  IV          6.7%              17.8 ± 0.5   11.0 ± 3.7   10.2 ± 3.3
  V           23.7%             18.1 ± 1.3   0.8 ± 0.4    0.7 ± 0.4
  VI          18.6%             17.6 ± 1.4   7.9 ± 7.7    7.7 ± 6.7
  VII         5%                16.6 ± 1.2   15.3 ± 0.6   15 ± 1.0

###### 

Wilcoxon non-parametric test to compare QOL scores registered at baseline, 3 and 6 months after surgery.

  ---------------------------------------------------------------------------
  Deviation   P-value         
  ----------- --------------- -----------------------------------------------
  I           T~0~ -- T~1~\   0.015[\*\*](#t3fn001){ref-type="table-fn"}\
              T~1~ -- T~2~\   0.172\
              T~0~ -- T~2~    0.019[\*\*](#t3fn001){ref-type="table-fn"}

  II          T~0~ -- T~1~\   0.080\
              T~1~ -- T~2~\   0.998\
              T~0~ -- T~2~    0.080

  III         T~0~ -- T~1~\   0.017[\*\*](#t3fn001){ref-type="table-fn"}\
              T~1~ -- T~2~\   0.082\
              T~0~ -- T~2~    0.005[\*\*\*](#t3fn002){ref-type="table-fn"}

  IV          T~0~ -- T~1~\   0.046[\*\*](#t3fn001){ref-type="table-fn"}\
              T~1~ -- T~2~\   0.058\
              T~0~ -- T~2~    0.027[\*\*](#t3fn001){ref-type="table-fn"}

  V           T~0~ -- T~1~\   0.000[\*\*\*](#t3fn002){ref-type="table-fn"}\
              T~1~ -- T~2~\   0.336\
              T~0~ -- T~2~    0.000[\*\*\*](#t3fn002){ref-type="table-fn"}

  VI          T~0~ -- T~1~\   0.000[\*\*\*](#t3fn002){ref-type="table-fn"}\
              T~1~ -- T~2~\   0.167\
              T~0~ -- T~2~    0.001[\*\*\*](#t3fn002){ref-type="table-fn"}

  VII         T~0~ -- T~1~\   0.057\
              T~1~ -- T~2~\   0.423\
              T~0~ -- T~2~    0.038[\*\*](#t3fn001){ref-type="table-fn"}
  ---------------------------------------------------------------------------

T~0~: baseline; T~1~: follow up 3 months; T~2~: follow up 6 months.

\*\*: \< 0,05

\*\*\*: \< 0,01.
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